Elevated levels of interleukin-18 and tumor necrosis factor-α in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier BV in Metabolism
- Vol. 52 (5), 605-608
- https://doi.org/10.1053/meta.2003.50096
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failureJCI Insight, 2001
- Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetesDiabetologia, 2001
- Increased Levels of Interleukin-18 in Patients with Pulmonary SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Increased Levels of Serum lnterleukin-18 in Graves' DiseaseThyroid®, 2000
- Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetesLife Sciences, 2000
- IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursorJCI Insight, 1999
- Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide TreatmentDiabetes Care, 1998
- Serum Levels of Tumor Necrosis Factor- Are Increased in Obese Patients with Noninsulin-Dependent Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 1998
- Circulating Tumor Necrosis Factor α is Elevated in Male but Not in Female Patients With Type II Diabetes MellitusHormone and Metabolic Research, 1997
- Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.JCI Insight, 1997